by Stephen Spotswood
For the past five years, Kara Zivin, PhD, MS, MA, has been “chasing burnout,” working to understand what causes it, how to measure it and what are the truly impactful measures that a healthcare system can take to combat it.
by U.S. Medicine
While veterans with locoregional non-small cell lung cancer (NSCLC) might find adjuvant chemotherapy beneficial, the risks might outweigh the benefit for some of them.
by U.S. Medicine
The VHA appears to fall short in providing equitable access to pre-operative care, which is associated with worse short- and long-term outcomes in clinical stage I non-small-cell lung cancer (NSCLC), according to a recent report.
by U.S. Medicine
The VA’s Frailty Index (VA-FI) was created to identify patients at high risk of unfavorable outcomes. A new study sought to determine how it works with older patients with non-small cell lung cancer (NSCLC).
by U.S. Medicine
New treatment guidelines endorsed highly effective hypertrophic cardiomyopathy management strategies, saying those have altered clinical course and substantially lowered mortality and morbidity rates.